FUTURE study
- Conditions
- nruptured cerebral aneurysm
- Registration Number
- JPRN-jRCTs052210149
- Lead Sponsor
- Imamura Hirotoshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
1) Over 20 years old and more at the time of consent acquisition
2) Patients planning to undergo Flow diverter placement for unruptured cerebral aneurysm
3) Patients who have been taking or are scheduled to take aspirin and clopidogrel for more than 5 days before procedure
4) Patients with written consent
1) Patients planning to change the content of antiplatelet drugs on the day of procedure
2) Patients on warfarin or direct oral anticoagulant (DOAC)
3) Patients contraindicated for MRI examination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cut-off values for ADP-MA and ADP-inhibition% for the incidence rate of symptomatic stroke
- Secondary Outcome Measures
Name Time Method Symptomatic ischemic stroke, high signal on diffusion-weighted images, hemorrhagic stroke